Zitra Medicines
PrivateLast Round
Grant
Jul 1, 2025
Total Funding Raised
$320,000
Company Overview
Zitra Medicines is a biotechnology company that develops mRNA-based therapeutics for severe brain diseases, including monogenic disorders, neurodegenerative conditions, and acute brain injury.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zitra Medicines Comparables
Compare Zitra Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ophidion Inc. | 81% | |
| Aerska | 80% | |
| Gate2Brain | 76% | |
Zitra Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2025 |
Zitra Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| mRNA Victoria | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2025
$320K grant received from mRNA Victoria.
Zitra Medicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Zitra Medicines's valuation, stock price, and market status.